Recarbrio

Imipenem/cilastatin/relebactam, sold under the brand name Recarbrio,[1] is a fixed-dose combination medication used as an antibiotic. In 2019, it was approved for use in the United States for the treatment of complicated urinary tract and complicated intra-abdominal infections.[2][3][4][5] It is administered via intravenous injection.[6][1] The most common adverse reactions include... [wikipedia]